TMCnet News
U.S. Patents Awarded to Inventors in Pennsylvania (Nov. 16)(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., Nov. 16 -- The following federal patents were awarded to inventors in Pennsylvania. *** Cisco Technology Assigned Patent for Phase Determination for Resampling Video ALEXANDRIA, Va., Nov. 16 -- Cisco Technology, San Jose, Calif., has been assigned a patent (8,310,595) developed by Maurice J. Buttimer, Media, Pa., Andrew P. Weir, Malvern, Pa., and Michael A. Arnao, Collegeville, Pa., for a "phase determination for resampling video." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method, and apparatus, and logic encoded in one or more computer-readable media to carry out a method. The method is to sample analog video at a sample clock rate and at a phase selected from a set of phases based on a quality measure determined from the sampled video. The quality measure is based on statistics of pixel to pixel differences in a coordinate of the generated digital video that have a magnitude exceeding a pre-determined threshold." The patent application was filed on April 21, 2008 (12/106,995). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,310,595&OS=8,310,595&RS=8,310,595 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** General Electric Assigned Patent for Automatic Brake Verification System ALEXANDRIA, Va., Nov. 16 -- General Electric, Schenectady, N.Y., has been assigned a patent (8,311,699) developed by Timothy Warren Brown, Erie, Pa., Ajith Kuttannair Kumar, Erie, Pa., and Henry Todd Young, North East, Pa., for an "automatic brake verification system." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method of testing a braking device in a drivetrain of a vehicle which includes at least one tractive element coupled to a traction motor. The method includes: (a) applying the braking device to a tractive element of the vehicle; (b) using an electronic controller, causing the traction motor to apply a predetermined force to the tractive element; and (c) using the controller, monitoring the tractive element for movement while the force is being applied. A dynamic braking or "retarder" function may also be tested. A system for carrying out the method is provided." The patent application was filed on Feb. 6, 2008 (12/026,976). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,311,699&OS=8,311,699&RS=8,311,699 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** CNH America Assigned Patent ALEXANDRIA, Va., Nov. 16 -- CNH America, New Holland, Pa., has been assigned a patent (8,311,709) developed by four co-inventors for an "implement initiated control of tractor power take-off (PTO)." The co-inventors are Olivier Vanhercke, Nieuwpoort, Belgium, Kevin M. Smith, Narvon, Pa., Chris Foster, Denver, Pa., and Riccardo Morselli, Modena, Italy. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A control system for managing the operation of a tractor PTO using input conditions occurring in a connected baler. Baler conditions such as tailgate position, crop pickup position, bale wrapper status, and driveline torque are sensed in the baler, and communicated to an implement-mounted controller whereupon control signals are initiated and communicated to a tractor-mounted controller to manage operation of the tractor's PTO. Safety may be maintained through the use of operator acknowledgements in order to prevent unexpected engagement of the PTO and a manual override capability allows an operator to suspend automated operation at any time." The patent application was filed on Sept. 8, 2009 (12/555,008). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,311,709&OS=8,311,709&RS=8,311,709 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** SRI International Assigned Patent ALEXANDRIA, Va., Nov. 16 -- SRI International, Menlo Park, Calif., has been assigned a patent (8,310,554) developed by four co-inventors for a "method and apparatus for performing coordinated multi-PTZ camera tracking." The co-inventors are Manoj Aggarwal, Plainsboro, N.J., Deepak Sethi, Bangalore, India, Supun Samarasekera, Princeton, N.J., and Vince Paragano, Yardley, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system for tracking at least one object is disclosed. The system includes a plurality of communicatively connected visual sensing units configured to capture visual data related to the at least one object The system also includes a manager component communicatively connected to the plurality of visual sensing units. The manager component is configured to assign one visual sensing unit to act as a visual sensing unit in a master mode and at least one visual sensing unit to act as a visual sensing unit in a slave mode. The manager component is further configured to transmit at least one control signal to the plurality of visual sensing units, and receive the visual data from the plurality of visual sensing units." The patent application was filed on Sept. 20, 2006 (11/524,134). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,310,554&OS=8,310,554&RS=8,310,554 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Franklin Electronic Publishers Assigned Patent ALEXANDRIA, Va., Nov. 16 -- Franklin Electronic Publishers, Burlington, N.J., has been assigned a patent (8,311,254) developed by Barry J. Lipsky, Burlington, N.J., and Eric A. Langberg, Milford, Pa., for a speaker system. The abstract of the patent published by the U.S. Patent and Trademark Office states: "An audio speaker comprises three modules stacked on one another to form a tower. The bottom module generates a magneto-strictive output that is coupled to the structure on which the bottom module stands to cause audio signal radiation from that structure. The top module has an upwardly facing cone speaker that radiates audio signals primarily in the upper audio frequency range. These two audio signal radiations combine to provide a more comprehensive frequency range signal than is normally obtained at the small size of the tower. An intermediate module plays media such as an audio card. The modules are releasably held together by embedded magnets in the adjacent facing surfaces of the modules. Signal information is transmitted between modules by terminals on adjacent facing surfaces. The upwardly facing surface has a set of recessed spring loaded upwardly extending terminals. The mating terminals on the downwardly facing surface are flush with the surface contact terminals." The patent application was filed on Sept. 21, 2010 (12/886,785). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,311,254&OS=8,311,254&RS=8,311,254 Written by Arpi Sharma; edited by Anand Kumar. *** nth Solutions Assigned Patent ALEXANDRIA, Va., Nov. 16 -- nth Solutions, Exton, Pa., has been assigned a patent (8,310,369) developed by Eric L. Canfield, Chester Springs, Pa., and Edward P. Cheslock, Delta, Pa., for a "detecting unintended flush toilet water flow." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Water is conserved by detecting unintended inflow of water into the tank of a flush toilet. A sensor acoustically and/or vibrationally coupled to the flush toilet detects sound and/or vibration generated due to turbulence in water flowing into the toilet tank. An electronic circuit analyzes the sensor output to detect cyclical water inflow not intended by a user. The electronic circuit generates an alert such as an audible and/or visual indication that the toilet is leaking." The patent application was filed on March 29, 2010 (12/748,793). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,310,369&OS=8,310,369&RS=8,310,369 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** CNH America Assigned Patent for Determination of Relative Position of Two Relatively Movable Elements ALEXANDRIA, Va., Nov. 16 -- CNH America, New Holland, Pa., has been assigned a patent (8,310,354) developed by six co-inventors for a "determination of relative position of two relatively movable elements." The co-inventors are John H. Posselius, Ephrata, Pa., Riccardo Morselli, San Vito di Spilamberto, Italy, Renzo Cicilloni, Brussels, Belgium, Andrea Saroldi, Turin, Italy, Maurizio Miglietta, Turin, Italy, and Silvano Marenco, Mondovi, Italy. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system for determining and/or controlling the relative position of two relatively movable elements, comprising a vehicle container combination, a utility vehicle including an unloading apparatus and at least three transmitting devices intended to be fitted, in use, in a predetermined spatial arrangement to one of the two relatively elements and configured to transmit respective signals; a single sensor device intended to be fitted, in use, to the other of the two relatively movable elements and configured to receive, and to determine the source direction (.psi..sub.i, .PHI..sub.i) of, the signals transmitted by the transmitting devices; and an electronic processing unit connected to the sensor device and configured to determine the relative position of the two relatively movable elements based on the source direction (.psi..sub.i, .PHI..sub.i) of the signals transmitted by the transmitting devices, and on the spatial arrangement of the transmitting devices." The patent application was filed on Sept. 3, 2009 (12/584,327). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,310,354&OS=8,310,354&RS=8,310,354 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Unisys Assigned Patent ALEXANDRIA, Va., Nov. 16 -- Unisys, Blue Bell, Pa., has been assigned a patent (8,312,117) developed by six co-inventors for a "dialog recovery in a distributed computer system." The co-inventors are Margaret Ann Magnotta, West Chester, Pa., Anthony Narisi, Glenmoore, Pa., Lois Bridgham Coyne, Lansdale, Pa., Michelle Marie Salvado, Exton, Pa., Susan Mary Jennion, Chester Springs, Pa., and Sarah K. Inforzato, Downingtown, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A distributed computer system comprises an enterprise server and a network server. The distributed computer system utilizes a distributed transmission control protocol (TCP) to establish an off-loaded dialog through the network server. If the off-loaded dialog is interrupted by, e.g., failure of the hosting network server, dialog recovery is performed to move the off-loaded dialog." The patent application was filed on Nov. 15, 2001 (10/000,674). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,312,117&OS=8,312,117&RS=8,312,117 Written by Arpi Sharma; edited by Anand Kumar. *** Animas Assigned Patent ALEXANDRIA, Va., Nov. 16 -- Animas, West Chester, Pa., has been assigned a patent (8,310,415) developed by Brian McLaughlin, Media, Pa., Ian M. Shipway, Bryn Mawr, Pa., and John Quinlan, Spring City, Pa., for a "medical devices using bistable displays." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention relates to a novel display system for a drug delivery device that reduces power consumption and permits the user of the device to see messages when the device is not in a powered state or when the device has encountered an error condition. By using a bistable display, the medical device is able to maintain messages that can been seen by the user even when the device's power supply is exhausted or when the device has encountered an error that interrupts its normal operation. The use of such a display also improves the battery life by eliminating the need to provide power to the display screen when it is not being updated." The patent application was filed on Sept. 30, 2009 (12/570,003). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,310,415&OS=8,310,415&RS=8,310,415 Written by Satyaban Rath; edited by Hemanta Panigrahi. *** Tiversa IP Assigned Patent ALEXANDRIA, Va., Nov. 16 -- Tiversa IP, Pittsburgh, has been assigned a patent (8,312,080) developed by Samuel P. Hopkins, Freedom, Pa., for a "system and method for searching for specific types of people or information on a peer to-peer network." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides a system and a method for searching for specific types of people or specific types of information on a Peer-to-Peer network, and in particular, using specific types of search terms as a means of profiling to find specific types of information or specific types of people on a Peer-to-Peer network. When a specific types of person or specific type of information is needed, a specific type of search term is issued on the Peer-to-Peer network. If that specific type of person or specific types of information is available a response will be received." The patent application was filed on March 23, 2012 (13/428,730). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,312,080&OS=8,312,080&RS=8,312,080 Written by Arpi Sharma; edited by Anand Kumar. *** Incyte Assigned Patent ALEXANDRIA, Va., Nov. 16 -- Incyte, Wilmington, Del., has been assigned a patent (8,309,718) developed by Yun-Long Li, Chadds Ford, Pa., Wenqing Yao, Kennett Square, Pa., and James D. Rodgers, Landenberg, Pa., for "4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides substituted bicyclic heteroaryl compounds, including, for example, 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines that modulate the activity of kinases and are useful in the treatment of diseases related to activity of kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases." The patent application was filed on Nov. 13, 2008 (12/270,135). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,09,718.PN.&OS=PN/83,09,718&RS=PN/83,09,718 Written by Amal Ahmed; edited by Jaya Anand. *** E I du Pont de Nemours Assigned Patent ALEXANDRIA, Va., Nov. 16 -- E I du Pont de Nemours, Wilmington, Del., has been assigned a patent (8,309,731) developed by seven co-inventors for an "electronic device including phenanthroline derivative." The co-inventors are Norman Herron, Newark, Del., Mark A. Guidry, Wilmington, Del., Vsevolod Rostovtsev, Swarthmore, Pa., Weiying Gao, Landenberg, Pa., Ying Wang, Wilmington, Del., Yulong Shen, Wilmington, Del., and Jeffrey A. Merlo, Wilmington, Del. The abstract of the patent published by the U.S. Patent and Trademark Office states: "There is provided an organic electronic device having an anode, a hole injection layer, a photoactive layer, an electron transport layer, and a cathode. At least one of the photoactive layer and the electron transport layer includes a compound having Formula I ##STR00001## where: R.sup.1 is the same or different and can be phenyl, biphenyl, naphthyl, naphthylphenyl, triphenylamino, or carbazolylphenyl; and one of the following conditions is met: (i) R.sup.2=R.sup.3 and is H, phenyl, biphenyl, naphthyl, naphthylphenyl, arylanthracenyl, phenanthryl, triphenylamino, or carbazolylphenyl; or (ii) R.sup.2 is H or phenyl; and R.sup.3 is phenyl, biphenyl, naphthyl, naphthylphenyl, arylanthracenyl, phenanthryl, triphenylamino, and carbazolylphenyl; When both R.sup.1 are phenyl, R.sup.2 and R.sup.3 can be 2-naphthyl, naphthylphenyl, arylanthracenyl, 9-phenanthryl, triphenylamino, or m-carbazolylphenyl." The patent application was filed on Nov. 18, 2011 (13/299,845). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,09,731.PN.&OS=PN/83,09,731&RS=PN/83,09,731 Written by Amal Ahmed; edited by Jaya Anand. *** Merck Sharp & Dohme Assigned Patent ALEXANDRIA, Va., Nov. 16 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,309,703) developed by Sameer Goregaoker, San Diego, John C. Hunter, Warren, N.J., and Tony Priestley, West Chester, Pa., for "compositions and methods for short interfering nucleic acid inhibition of Na.sub.v1.8." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides short interfering nucleic acids, either single-stranded or double-stranded, that cause RNAi-induced degradation of mRNA from the Na.sub.v1.8 sodium channel gene; to pharmaceutical compositions comprising such short interfering nucleic acids; recombinant vectors comprising such short interfering nucleic acids; a method for inhibiting translation of an mRNA; a method for inhibiting expression of a polypeptide; a method for blocking the membrane potential in a cell; a method for blocking the sodium current in a cell; and a method for inhibiting chronic pain." The patent application was filed on May 28, 2010 (12/789,564). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,09,703.PN.&OS=PN/83,09,703&RS=PN/83,09,703 Written by Amal Ahmed; edited by Jaya Anand. *** PBI Performance Products Assigned Patent ALEXANDRIA, Va., Nov. 16 -- PBI Performance Products, Charlotte, N.C., has been assigned a patent (8,309,662) developed by four co-inventors for "polybenzimidazole-polyetherketoneketone blends and miscible blends." The co-inventors are Bobby G. Dawkins, Charlotte, N.C., Michael Gruender, Charlotte, N.C., Gregory S. Copeland, Tega Cay, S.C., and Tim Hsu, State College, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A process for producing a solution blend of a polybenzimidazole (PBI) and a polyetherketoneketone (PEKK). The PBI is mixed with sulfuric acid at a temperature between 40.degree. C. and 80.degree. C. for 30 minutes to 2 hours to produce a PBI solution then cooled to room temperature to form a cooled PBI solution. Then PEKK is added to the cooled PBI solution to form a mixture and that mixture is stirred from 30 minutes to 2 hours at room temperature to form a stirred mixture. The stirred mixture is poured into an excess of water being stirred swiftly to form an aqueous mixture. The aqueous mixture is filtered to produce a blend. The blend is washed with water and dried. The resulting blend can yield a blend in all proportion from 1/99 PBI/PEKK to 99/1 PBI/PEKK." The patent application was filed on July 22, 2010 (12/841,277). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,09,662.PN.&OS=PN/83,09,662&RS=PN/83,09,662 Written by Amal Ahmed; edited by Jaya Anand. *** Rohm and Haas Assigned Patent ALEXANDRIA, Va., Nov. 16 -- Rohm and Haas, Philadelphia, has been assigned a patent (8,309,651) developed by five co-inventors for a binder composition. The co-inventors are William C. Finch, Ambler, Pa., Griffin M. Gappert, Philadelphia, Michael D. Kelly, North Wales, Pa., Hal C. Morris, Abington, Pa., and Xun Tang, Dresher, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A binder composition comprising an emulsion copolymer, and a polyol crosslinker." The patent application was filed on Nov. 24, 2008 (12/313,712). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,09,651.PN.&OS=PN/83,09,651&RS=PN/83,09,651 Written by Amal Ahmed; edited by Jaya Anand. *** Rohm and Haas Assigned Patent for Microbiocidal Coatings ALEXANDRIA, Va., Nov. 16 -- Rohm and Haas, Philadelphia, has been assigned a patent (8,309,626) developed by seven co-inventors for microbiocidal coatings. The co-inventors are Henry Huan Chen, Shanghai, China, Jennifer Reichl Collin, Devon, Pa., Lynn Carol Munz, Harleysville, Pa., Christopher John Tucker, Midland, Mich., Janet Nadya Younathan, Lansdale, Pa., Yonnie Dong Yun, Shanghai, China, and Fanwen Zeng, Belle Mead, N.J. The abstract of the patent published by the U.S. Patent and Trademark Office states: "There is provided a coating composition comprising (a) one or more microbicide, (b) one or more soluble polymer comprising acrylamide as polymerized units, wherein said polymer has is non-anionic, and (c) solvent, wherein said polymer is dissolved in said solvent. Also provided is a method of coating a substrate with such a coating, and also provided is the resulting coated substrate." The patent application was filed on July 11, 2011 (13/179,639). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,09,626.PN.&OS=PN/83,09,626&RS=PN/83,09,626 Written by Amal Ahmed; edited by Jaya Anand. *** Lyondell Chemical Technology Assigned Patent ALEXANDRIA, Va., Nov. 16 -- Lyondell Chemical Technology, Houston, has been assigned a patent (8,309,758) developed by Stephen H. Harris, Kennett Square, Pa., and Shaw-Chan Lin, West Chester, Pa., for an allyl acetate purification. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A process for purifying allyl acetate is disclosed. An acetoxylation mixture is distilled at elevated pressure to remove propylene and generate a first bottoms mixture comprising allyl acetate, acetic acid, acrolein, allyl diacetate, and 3-acetoxypropionaldehyde. The first bottoms mixture is flash vaporized, and the resulting vapor is contacted with a solid acidic catalyst under conditions effective to decompose allyl diacetate and 3-acetoxypropionaldehyde. The flashed product, which comprises allyl acetate, acetic acid, and acrolein, is then distilled to remove acrolein and generate a second bottoms mixture comprising allyl acetate and acetic acid. The second bottoms mixture can be used to manufacture allyl alcohol." The patent application was filed on Dec. 17, 2009 (12/653,677). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,09,758.PN.&OS=PN/83,09,758&RS=PN/83,09,758 Written by Amal Ahmed; edited by Jaya Anand. *** Centocor Ortho Biotech Assigned Patent ALEXANDRIA, Va., Nov. 16 -- Centocor Ortho Biotech, Horsham, Pa., has been assigned a patent (8,309,688) developed by Adam Cotty, Radnor, Pa., and Michael Naso, Radnor, Pa., for a "monkey homolog of human oncostatin M and methods of use thereof." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Cytokine oncostatin M nucleic acids from Cynomolgus monkey are useful for expression of oncostatin M proteins that are functional homologs of human oncostatin M. The nucleic acids and proteins produced therefrom are useful in screening and safety testing of oncostatin M, the generation and testing of oncostatin M modulators and related activities." The patent application was filed on Dec. 29, 2009 (12/648,430). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,09,688.PN.&OS=PN/83,09,688&RS=PN/83,09,688 Written by Amal Ahmed; edited by Jaya Anand. *** NetApp Assigned Patent for System and Method for Enabling a Data Container to Appear in a Plurality of Locations in a Super-namespace ALEXANDRIA, Va., Nov. 16 -- NetApp, Sunnyvale, Calif., has been assigned a patent (8,312,046) developed by five co-inventors for a "system and method for enabling a data container to appear in a plurality of locations in a super-namespace." The co-inventors are Michael Eisler, Colorado Springs, Colo., Daniel S. Nydick, Wexford, Pa., Peter F. Corbett, Lexington, Mass., Michael Kazar, Pittsburgh, and J. Christopher Wagner, Langley, Wash. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system and method to allow a volume to appear in multiple locations in a super-namespace. A super-namespace is a hierarchy of namespaces within a storage system environment, such as a storage system cluster. The volume can appear in multiple locations in the super-namespace and/or in multiple namespaces within the super-namespace." The patent application was filed on Feb. 28, 2007 (11/680,255). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,312,046&OS=8,312,046&RS=8,312,046 Written by Arpi Sharma; edited by Anand Kumar. *** Rohm and Haas Assigned Patent for Aqueous Silica Dispersion ALEXANDRIA, Va., Nov. 16 -- Rohm and Haas, Philadelphia, has been assigned a patent (8,309,615) developed by Joseph Michael Hoefler, Bensalem, Pa., for an aqueous silica dispersion. The abstract of the patent published by the U.S. Patent and Trademark Office states: "An aqueous silica dispersion containing silica particles dispersed in an aqueous medium is provided. The surfaces of the silica particles are treated with reacted aminosilane compound. The aqueous silica dispersion also contains anionic polymeric dispersing agent. The dispersion of the silica particles into an aqueous medium containing both anionic polymeric dispersing agent and aminosilane compound allows the preparation of aqueous silica dispersions at higher solids and/or low viscosities than aqueous silica dispersions that are prepared without either the anionic polymeric dispersing agent or the aminosilane compound. The aqueous silica dispersion is combinable with aqueous emulsion polymers to modify the physical or appearance properties of articles formed from the emulsion polymer." The patent application was filed on March 31, 2006 (11/395,821). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,09,615.PN.&OS=PN/83,09,615&RS=PN/83,09,615 Written by Amal Ahmed; edited by Jaya Anand. *** Bristol-Myers Squibb Assigned Patent for Heterobicyclic Compounds Useful as Kinase Inhibitors ALEXANDRIA, Va., Nov. 16 -- Bristol-Myers Squibb, Princeton, N.J., has been assigned a patent (8,309,571) developed by T. G. Murali Dhar, Newtown, Pa., and Stephen T. Wrobleski, Whitehouse Station, N.J., for "heterobicyclic compounds useful as kinase inhibitors." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A compound of Formula (I) ##STR00001## and enantiomers, diastereomers and pharmaceutically-acceptable salts thereof. Also disclosed are pharmaceutical compositions containing compounds of Formula I, and methods of treating conditions associated with the activity of p38 kinase." The patent application was filed on April 12, 2011 (13/084,622). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,09,571.PN.&OS=PN/83,09,571&RS=PN/83,09,571 Written by Amal Ahmed; edited by Jaya Anand. *** Agere Systems Assigned Patent ALEXANDRIA, Va., Nov. 16 -- Agere Systems, Allentown, Pa., has been assigned a patent (8,310,275) developed by Edward B. Harris, Fogelsville, Pa., and Che Choi Leung, Bethlehem Township, Northampton County, Pa., for a "high voltage tolerant input/output interface circuit." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An IO interface circuit for use in a high voltage tolerant application is provided. The IO interface circuit includes a signal pad and at least a first parasitic bipolar transistor having an emitter adapted for connection to a voltage return of the interface circuit, a base adapted to receive a first control signal, and a collector connected directly to the signal pad in an open collector configuration. The interface circuit further includes a MOS control circuit coupled to the parasitic bipolar transistor and being operative to generate the first control signal. The IO interface circuit may further include an active pull-up circuit connected between a voltage supply of the interface circuit and the signal pad." The patent application was filed on Oct. 01, 2009 (12/439,389). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,10,275.PN.&OS=PN/83,10,275&RS=PN/83,10,275 Written by Kusum Sangma; edited by Anand Kumar. *** Rohm and Haas Assigned Patent for Synergistic Microbicidal Compositions ALEXANDRIA, Va., Nov. 16 -- Rohm and Haas, Philadelphia, has been assigned a patent (8,309,588) developed by Megan Ann Diehl, Line Lexington, Pa., and Dolores A. Shaw, Collegeville, Pa., for synergistic microbicidal compositions. The abstract of the patent published by the U.S. Patent and Trademark Office states: "This invention relates to synergistic combinations of selected microbicides in combination with a second microbicide or formulation ingredient or raw material. The combinations have greater efficacy than would be expected from combinations of the individual components. The combinations include mixtures of (a) 5-Chloro-2-methyl-4-isothiazolin-3-one+2-Methyl-4-isothiazolin-3-one, (b) Methyl-4-isothiazolin-3-one, or (c) 1,2-Benzisothiazolin-3-one with one or more of a variety of other compounds." The patent application was filed on May 19, 2011 (13/111,006). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,09,588.PN.&OS=PN/83,09,588&RS=PN/83,09,588 Written by Amal Ahmed; edited by Jaya Anand. *** Google Assigned Patent for Electronic Shipping Notifications ALEXANDRIA, Va., Nov. 16 -- Google, Mountain View, Calif., has been assigned a patent (8,311,952) developed by Eric Lundberg, Lebanon, Pa., and Pengyue Yang, Mountain View, Calif., for electronic shipping notifications. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A broker facilitates customer purchases from merchants. Shippers ship shipments containing the purchases from merchants to the customers. A shipper identifies a shipment using a shipment identifier. The broker uses the shipment identifier to obtain the status information for the shipment from the shipper. The broker analyzes the status information in combination with other information to calculate an estimate of the time that the shipment will arrive at the customer's address. The broker sends an electronic message, such as an email or text message, to the customer prior to the estimated shipment arrival time to inform the customer of the impending arrival. The customer can thus arrange for someone to be at the shipping address to receive the shipment at the estimated arrival time." The patent application was filed on March 2, 2012 (13/411,122). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,11,952.PN.&OS=PN/83,11,952&RS=PN/83,11,952 Written by Amal Ahmed; edited by Jaya Anand. *** AbbVie Assigned Patent ALEXANDRIA, Va., Nov. 16 -- AbbVie, North Chicago, Ill., has been assigned a patent (8,309,613) developed by seven co-inventors for a "solid pharmaceutical dosage form." The co-inventors are Joerg Rosenberg, Ellerstadt, Germany, Ulrich Reinhold, Heidelberg, Germany, Bernd Liepold, Dossenheim, Germany, Gunther Berndl, Herxheim, Germany, Joerg Breitenbach, Mannheim, Germany, Laman Alani, Foster City, Calif., and Soumojeet Ghosh, Lansdale, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "A solid pharmaceutical dosage form providing improved oral bioavailability is disclosed for inhibitors of HIV protease. In particular, the dosage form comprises a solid dispersion of at least one HIV protease inhibitor and at least one pharmaceutically acceptable water-soluble polymer and at least one pharmaceutically acceptable surfactant, said pharmaceutically acceptable water-soluble polymer having a Tg of at least about 50.degree. C. Preferably, the pharmaceutically acceptable surfactant has an HLB value of from about 4 to about 10." The patent application was filed on Sept. 13, 2010 (12/880,781). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,09,613.PN.&OS=PN/83,09,613&RS=PN/83,09,613 Written by Amal Ahmed; edited by Jaya Anand. *** Tandent Vision Science Assigned Patent ALEXANDRIA, Va., Nov. 16 -- Tandent Vision Science, San Francisco, has been assigned a patent (8,311,338) developed by five co-inventors for a "method and system for learning a same-material constraint in an image." The co-inventors are Andrew Neil Stein, Pittsburgh, Bartholomeus Christianus Leonardus Nabbe, Hillsboro, Ore., Casey Arthur Smith, Grand Junction, Colo., James Andrew Bagnell, Pittsburgh, and David Allen Tolliver, Pittsburgh. The abstract of the patent published by the U.S. Patent and Trademark Office states: "In a first exemplary embodiment of the present invention, an automated, computerized method is provided for processing an image. According to a feature of the present invention, the method comprises the steps of providing an image file depicting an image, in a computer memory, assembling a feature vector for the image file, the feature vector containing information regarding a likelihood that a selected pair of regions of the image file are of a same intrinsic characteristic, providing a classifier derived from a computer learning technique, computing a classification score for the selected pair of regions of the image file, as a function of the feature vector and the classifier and classifying the regions as being of the same intrinsic characteristic, as a function of the classification score." The patent application was filed on Sept. 15, 2009 (12/584,910). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,311,338.PN.&OS=PN/8,311,338&RS=PN/8,311,338 Written by Kusum Sangma; edited by Anand Kumar. *** University of Pittsburgh-of the Commonwealth System of Higher Education Assigned Patent ALEXANDRIA, Va., Nov. 16 -- The University of Pittsburgh-of the Commonwealth System of Higher Education, Pittsburgh, has been assigned a patent (8,309,599) developed by Kazunori Koide, Pittsburgh, Brian J. Albert, Pittsburgh, and Ananthapadmanabhan Sivaramakrishnan, Jamestown, N.C., for a "synthesis of FR901464 and analogs with antitumor activity." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides novel analogs of FR901464, as well as an improved methodology for preparing FR901464 and its analogs. These compounds display an anti-cancer activity and are candidates for therapies against a number of disease states associated with dysfunctional RNA splicing." The patent application was filed on Sept. 15, 2010 (12/883,105). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=83,09,599.PN.&OS=PN/83,09,599&RS=PN/83,09,599 Written by Amal Ahmed; edited by Jaya Anand. *** University of the Holy Spirit Assigned Patent ALEXANDRIA, Va., Nov. 16 -- The University of the Holy Spirit, Pittsburgh, has been assigned a patent (8,309,564) developed by Aleem Gangjee, Allison Park, Pa., for "tricyclic compounds having antimitotic and/or antitumor activity and methods of use thereof." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention provides tricyclic compounds, pharmaceutically acceptable salts, prodrugs, solvates, or hydrates thereof, having antimitotic activity, anti-multidrug resistance activity, for example P-glycoprotein inhibition, and antitumor activity, and which inhibit paclitaxel sensitive and resistant tumor cells. Also provided are methods of utilizing these compounds for treating tumor cells and inhibiting mitosis of cancerous cells." The patent application was filed on June 2, 2011 (13/151,530). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,309,564&OS=8,309,564&RS=8,309,564 Written by Neha Bharti; edited by Jaya Anand. *** Merck Sharp & Dohme Assigned Patent ALEXANDRIA, Va., Nov. 16 -- Merck Sharp & Dohme, Rahway, N.J., has been assigned a patent (8,309,540) developed by five co-inventors for "HCV NS3 protease inhibitors." The co-inventors are Nigel J. Liverton, Harleysville, Pa., Joseph P. Vacca, Telford, Pa., John A. McCauley, Maple Glen, Pa., Joseph J. Romano, Berwyn, Pa., and Michael T. Rudd, Collegeville, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections. (I) ##STR00001##." The patent application was filed on Oct. 22, 2007 (12/446,763). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,309,540&OS=8,309,540&RS=8,309,540 Written by Neha Bharti; edited by Jaya Anand. *** Penn State Research Foundation Assigned Patent ALEXANDRIA, Va., Nov. 16 -- Penn State Research Foundation, University Park, Pa., has been assigned a patent (8,309,541) developed by four co-inventors for "anti-cancer compositions and methods." The co-inventors are Gavin P. Robertson, Hummelstown, Pa., SubbRao V. Madhunapantula, Hershey, Pa., Shantu Amin, Union City, N.J., and Dhimant Desai, Mechanicsburg, Pa. The abstract of the patent published by the U.S. Patent and Trademark Office states: "Anti-cancer compositions and methods are described including one or more compounds having the structural formula I: R2-R-R1, where R is phenyl, where R1 is (CH.sub.2).sub.nSe--C(.dbd.NH)--NH.sub.2, where R2 is (CH.sub.2).sub.nSe--C(.dbd.NH)--NH.sub.2 or R2 is H, and where each n is independently 2, 3, 4, 5, 6, 7, or 8. Methods of treating a subject are provided according to embodiments of the present invention which include administering a therapeutically effective amount of a composition including one or more compounds having the structural formula I to a subject having a condition characterized by Akt dysregulation. Administering a therapeutically effective amount of a composition including one or more compounds having the structural formula I to a subject detectably increases apoptosis and/or decreases proliferation of cancer cells, particularly cancer cells characterized by Akt dysregulation. Compositions of the present invention inhibit Akt enzymes, iNOS, and increase MAP kinase activity such that cancer cells contacted with the compositions are inhibited." The patent application was filed on May 13, 2011 (13/107,494). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,309,541&OS=8,309,541&RS=8,309,541 Written by Neha Bharti; edited by Jaya Anand. For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; [email protected]; http://targetednews.com. -1105613 (c) 2012 Targeted News Service |